Display options
Cite
Vilain J, Degols JC, Ledeghen S. Recurrent Adenomatous Neuroendocrine Tumor of the Middle Ear: A Diagnostic Challenge. Case Rep Otolaryngol. 2018;2018:8619434doi: 10.1155/2018/8619434.
Vilain, J., Degols, J. C., & Ledeghen, S. (2018). Recurrent Adenomatous Neuroendocrine Tumor of the Middle Ear: A Diagnostic Challenge. Case reports in otolaryngology, 20188619434. https://doi.org/10.1155/2018/8619434
Vilain, J, et al. "Recurrent Adenomatous Neuroendocrine Tumor of the Middle Ear: A Diagnostic Challenge." Case reports in otolaryngology vol. 2018 (2018): 8619434. doi: https://doi.org/10.1155/2018/8619434
Vilain J, Degols JC, Ledeghen S. Recurrent Adenomatous Neuroendocrine Tumor of the Middle Ear: A Diagnostic Challenge. Case Rep Otolaryngol. 2018 Nov 25;2018:8619434. doi: 10.1155/2018/8619434. eCollection 2018. PMID: 30595934; PMCID: PMC6286763.
Copy Download .nbib Format: NLM
Share it on

Case Rep Otolaryngol. 2018 Nov 25;2018:8619434. doi: 10.1155/2018/8619434. eCollection 2018.

Recurrent Adenomatous Neuroendocrine Tumor of the Middle Ear: A Diagnostic Challenge.

Case reports in otolaryngology

J Vilain, J-C Degols, S Ledeghen

Affiliations

  1. ENT Department, Clinique Saint-Pierre, 9 Av Reine Fabiola, 1340 Ottignies LLN, Belgium.

PMID: 30595934 PMCID: PMC6286763 DOI: 10.1155/2018/8619434

Abstract

Middle ear adenomatous neuroendocrine tumor (MEANT) poses a diagnostic challenge. Clinical symptoms are nonspecific. Definite diagnosis is made by histopathological analysis of the tumor after a complete surgical resection based on an extensive computed tomography/magnetic resonance imaging (CT/MRI). Controversial terminology of the neoplasm arises from the differentiation of this tumor composed of both endocrine and exocrine glands. Middle ear (ME) localization is rare and less aggressive than gastrointestinal tract or lung localizations. Nevertheless, clinical and CT/MRI analyses are necessary follow-ups for preventing or detecting recurrence or metastasis. A case of a female patient aged 26 with recurrent middle ear neuroendocrine adenoma is presented herein.

References

  1. Clin Otolaryngol Allied Sci. 1976;1(1):17-26 - PubMed
  2. Mod Pathol. 2002 May;15(5):543-55 - PubMed
  3. Oncologist. 2005 Feb;10(2):123-31 - PubMed
  4. Laryngoscope. 2005 Sep;115(9):1660-6 - PubMed
  5. Arch Pathol Lab Med. 2006 Jul;130(7):1067-9 - PubMed
  6. Clin Nucl Med. 2007 Jun;32(6):466-7 - PubMed
  7. AJNR Am J Neuroradiol. 2009 Sep;30(8):1602-3 - PubMed
  8. Cases J. 2009 Mar 13;2:6508 - PubMed
  9. Laryngoscope. 2013 Mar;123(3):779-82 - PubMed
  10. Clin Med (Lond). 2012 Aug;12(4):377-80 - PubMed
  11. Otol Neurotol. 2012 Oct;33(8):1418-21 - PubMed
  12. Ann Surg Oncol. 2013 Feb;20(2):640-5 - PubMed
  13. Head Neck Pathol. 2014 Mar;8(1):24-32 - PubMed
  14. Virchows Arch. 2017 Nov;471(5):667-672 - PubMed
  15. Int Arch Otorhinolaryngol. 2017 Jul;21(3):308-312 - PubMed
  16. Otol Neurotol. 2018 Sep;39(8):e712-e721 - PubMed
  17. Laryngoscope. 1976 Aug;86(8):1123-35 - PubMed

Publication Types